You are here

Santarus

Santarus Plans NDA Filing On Key New Drug

Seeking Alpha

Tue, 10/4/11 - 11:25 am

ulcerative colitis

Santarus: Weighing A Promising Pipeline Against Patent Challenges

Seeking Alpha

Sat, 09/17/11 - 04:10 pm

Santarus CEO Discusses Q2 2011 Results - Earnings Call Transcript

Seeking Alpha

Thu, 08/4/11 - 09:28 am

FDA rejects filing on Santarus angioedema drug

Yahoo/AP

Mon, 02/28/11 - 12:17 pm

Santarus climbs on FDA submission

Marketwatch

Tue, 12/28/10 - 11:56 am

hereditary angiodema

Santarus Hit by Generic Zegerid

Yahoo/Zacks.com

Wed, 11/17/10 - 12:52 pm

Par Pharmaceutical

Santarus' Q3 Loss: The Rough Path to Recovery

Seeking Alpha

Wed, 11/10/10 - 10:49 am

Santarus reports 3Q loss on sales drop, costs

Yahoo/AP

Tue, 11/9/10 - 08:07 am

Santarus says colitis drug met goal in study

Yahoo/AP

Thu, 09/30/10 - 11:09 am

ulcerative colitis

Santarus: Building a New Company on Zegerid’s Ashes

Seeking Alpha

Mon, 09/27/10 - 10:45 am

Santarus: A Stock With Potential to Run

Seeking Alpha

Tue, 09/21/10 - 11:16 am

Santarus Adds Two Novel Biologic Drug Candidates to Pipeline

Yahoo

Mon, 09/13/10 - 12:14 pm

Santarus licenses approved diabetes drug for $5M

Yahoo/AP

Fri, 09/10/10 - 09:29 am

Santarus jumps on drug launch news

Marketwatch

Thu, 09/9/10 - 11:21 am

Santarus Beats on Higher Revs

Yahoo/Zacks.com

Wed, 08/4/10 - 01:48 pm

Prasco to market Zegerid generic

Bizjournals.com

Thu, 07/1/10 - 04:35 pm

Santarus tumbles on court patent ruling

Marketwatch

Thu, 04/15/10 - 10:06 am

Dynavax, Santarus: Early Volume Plays

TheStreet.com

Thu, 04/15/10 - 08:46 am

Santarus eyes Phase III trials for diarrhea drug

Marketwatch

Wed, 12/30/09 - 09:18 am

Santarus on a Roll

Yahoo/Zacks.com

Mon, 12/7/09 - 12:32 pm

Pages